SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper

ZUG, Switzerland, Dec. 8, 2021 /PRNewswire/ -- SHL Medical, a world-leading solutions provider in the design, development, and manufacturing of self-injection devices, announced the publication of its white paper titled, "MollyA® Autoinjector: A Systematic Review of Molly's Integrated and Flexible Design and Development Model".
SHL Medical Publishes its Molly Modular Autoinjector Platform Technology White Paper
With various platform autoinjector offerings emerging in the market, SHL Medical sought to redefine the conventional platform model by adding modularity to its Molly device technology. In 2010, SHL's Molly was originally designed to be a preconfigured offering leveraging communal infrastructure to save costs and shorten timelines. The Molly technology has since supported the commercial launch of 17 combination products covering at least 25 clinical indications across various diseases areas. Ten years after, the second generation of Molly was born a?? now a modularized technology that goes beyond the confines of platform-based devices. This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model. The work is a result of research and discussions with various subject-matter experts from SHL's technical teams. It outlines SHL's predictive response to market imperatives in the medical device industry, resulting in a constantly expanding Molly ecosystem that supports product customization and effective lifecycle management.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2022    »